GLPwatch
Papers (10382)
Page 123 of 174, ranked by citation count.
- Carbol fuchsin stain enhances detection of poly-(d, l-lactide-co-glycolide) microspheres in exenatide extended-release cutaneous injection-site foreign body reaction.
- Incorporating glucagon-like peptide-1 receptor agonists into clinical practice.
- Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial.
- Global Rise of Compounded Weight-Loss Medicines: A Worrisome Trend.
- Future is Brighter: New Potential Paradigm-Shifting Medications and Regimens for Diabetes and Obesity.
- Semaglutide, Ertugliflozin, and Deflazacort.
- Tirzepatide increased force of contraction in the isolated human atrium.
- Development of Flow-NMR Spectroscopy for Real-Time Monitoring and Kinetics Studies of Biomolecules: Case Study of Liraglutide Oligomerization.
- Healthcare resource utilization and related financial costs associated with glucose lowering with either exenatide or basal insulin: A retrospective cohort study.
- Real-World Effectiveness of Tirzepatide versus Semaglutide on HbA1c and Weight in Patients with Type 2 Diabetes.
- Semaglutide and human reproduction: caution at the intersection of energy balance, ovarian function, and follicular development.
- Inhibitory effect of exendin-4 on secretory group IIA phospholipase A2.
- Efficacy and Safety of Once-Weekly Subcutaneous Semaglutide in Overweight or Obese Adults: A Systematic Review with Meta-Analysis.
- Impact of the injectable weight-loss medications, glucagon-like peptide-1 receptor agonists, on reproductive health in non-polycystic ovary syndrome state.
- Liraglutide treatment and acylcarnitine profiles in Egyptian obese insulin-resistant females.
- Tirzepatide gains US Food and Drug Administration approval for the management of obstructive sleep apnea: Implications for oral health care providers.
- Liraglutide modulates morpho-functional and inflammatory gastrointestinal responses in rats.
- Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants.
- Liraglutide and Liver Injury: Rare Case Report with Literature Review.
- Exendin-4 attenuates inflammation-mediated endothelial cell apoptosis in varicose veins through inhibiting the MAPK-JNK signaling pathway.
- Scientific report: a case of acute pancreatitis due to liraglutide.
- Generation and characterisation of a humanised GLP-1 receptor mouse model for translational drug development.
- Drug-Induced Liver Injury Due to Dulaglutide Use.
- Treatment effect of semaglutide 2.4 mg on health-related quality of life from STEP 1 SF-6D derived from SF-36 with Australian weights.
- Dopamine signalling in pancreatic islet cells and role in adaptations to metabolic stress.
- IcoSema: unveiling the future of diabetes management from a clinical pharmacology perspective.
- Elderly rats fed with a high-fat high-sucrose diet developed sex-dependent metabolic syndrome regardless of long-term metformin and liraglutide treatment.
- Weight change from incretin-based weight loss medications across categories of second-generation antipsychotics.
- Dulaglutide and a Composite Outcome Reflecting Atherosclerosis in the REWIND Trial: A Post Hoc Analysis.
- Anagliptin, a dipeptidyl peptidase-4 inhibitor, improved bladder function and hemodynamics in rats with bilateral internal iliac artery ligation.
- Metabolic effects of combined glucagon receptor antagonism and glucagon-like peptide-1 receptor agonism in high fat fed mice.
- Characteristics of WBN/Kob diabetic fatty rats supplemented with a fructose-rich diet as a metabolic syndrome model: response to a GLP-1 receptor agonist.
- Repeated Withdrawal of a GLPR Agonist Induces Hyperleptinemia and Deteriorates Metabolic Health in Obese Aging UM-HET3 Mice.
- Unlocking the potential of glucagon-like peptide-1 receptor agonists in revolutionizing type 2 diabetes management: a comprehensive review.
- Liraglutide attenuates clozapine-induced mitochondrial dysfunction and improves energy metabolism in the brain of rats.
- Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study.
- A Randomized, Double-Blind, Two-Way Cross-over Study to Evaluate the Efficacy of Liraglutide Treatment in Patients Undergoing Transoral Outlet Reduction Endoscopy for Weight Regain Post Roux-en-Y Gastric Bypass.
- Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world (STEER).
- The efficacy and safety of insulin glargine 100 U/mL + lixisenatide versus insulin degludec + insulin aspart in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli-D randomized controlled trial.
- In HFpEF with obesity, semaglutide improved health status and weight loss at 52 wk, regardless of initial health status.
- Comparative Analysis of the Anti-Inflammatory Effects of Liraglutide and Dulaglutide.
- Cardiovascular Effects of Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
- Comparative study on anorexigenic effect of glucagon-like peptide-1 receptor agonists in rats.
- Long-lasting Glucagon-like Peptide 1 Analogue Exendin-4 Ameliorates the Secretory and Synthetic Function of Islets Isolated From Severely Scalded Rats.
- Cost-Effectiveness of Dulaglutide Versus Liraglutide for Management of Type 2 Diabetes Mellitus in Iran.
- Real-world efficacy of tirzepatide in patients with heart failure without diabetes.
- Allodynia and Dysesthesia Associated With Semaglutide and Tirzepatide.
- [The incretin effect and type 2 diabetes].
- Addition of once daily prandial lixisenatide to basal insulin therapy in patients with type-2 diabetes results in a reduction of HbA1c as an effect of postprandial glucose lowering.
- Tirzepatide and the Prevention of Heart Failure in Obesity: A Multi-Center Cohort Study Using the TriNetX Database.
- Effect of exenatide on gastric emptying and graft survival in islet allograft recipients.
- Oral semaglutide - Rybelsus®, the first GLP-1 receptor agonist for oral use in clinical practice.
- Efficacy and safety of fixed-ratio combination insulin degludec/liraglutide in type 2 diabetes: A systematic review and meta-analysis of randomised controlled trials.
- Impact of semaglutide exposure on fetal and neonatal outcomes in pregnant women: a systematic review.
- Investigating the potential non-authorized use of two different formulations of liraglutide in Europe: A real-world drug utilization study.
- The effect of dulaglutide on glycated hemoglobin is associated with PNPLA3 Ι148Μ gene polymorphism in patients with type 2 diabetes mellitus.
- Exendin-4 improves resistance to Listeria monocytogenes infection in diabetic db/db mice.
- Microvascular and macrovascular effects of liraglutide.
- Future Medications for Obesity and Clinical Implications.
- Time to approve glucagon-like peptide-1 receptor agonists for MASLD: a rational step based on robust evidence.